{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:01:38Z","timestamp":1771660898630,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Commission-Horizon 2020"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jcv.2020.104539","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T11:33:38Z","timestamp":1594035218000},"page":"104539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test"],"prefix":"10.1016","volume":"129","author":[{"given":"Silvia","family":"Meschi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Colavita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licia","family":"Bordi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2948-4243","authenticated-orcid":false,"given":"Giulia","family":"Matusali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Vairo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Capobianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9819-236X","authenticated-orcid":false,"given":"Concetta","family":"Castilletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2020.104539_bib0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.jcv.2020.104539_bib0010","series-title":"(WHO) Rolling Updates on Coronavirus Disease (COVID-19) Outbreak Situation","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.jcv.2020.104539_bib0015","author":"Centers for Disease Control and Prevention (CDC)"},{"issue":"2","key":"10.1016\/j.jcv.2020.104539_bib0020","first-page":"137","article-title":"Current laboratory diagnostics of coronavirus disease 2019 (COVID-19)","volume":"91","author":"Lippi","year":"2020","journal-title":"Acta Biomed."},{"key":"10.1016\/j.jcv.2020.104539_bib0025","series-title":"Developing a National Strategy for Serology (Antibody Testing) in the United States Johns Hopkins Center for Health Security; 621 E. Pratt Street, Suite 210, Baltimore, MD 21202; April 22nd","author":"Gronvall","year":"2020"},{"key":"10.1016\/j.jcv.2020.104539_bib0030","series-title":"Communication From the Commission Guidelines on COVID-19 in Vitro Diagnostic Tests and Their Performance. Official Journal of the European Union 2020\/C 122 I\/01C\/2020\/2391","author":"European Commission","year":"2020"},{"key":"10.1016\/j.jcv.2020.104539_bib0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/v11040373","article-title":"Inflammatory and humoral immune response during ebola virus infection in survivor and fatal cases occurred in Sierra Leone during the 2014\u20132016 outbreak in West Africa","volume":"11","author":"Colavita","year":"2019","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.jcv.2020.104539_bib0040","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.11.2000266","article-title":"Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020","volume":"25","author":"Haveri","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jcv.2020.104539_bib0045","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00941-20","article-title":"Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho","author":"Bryan","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"March","key":"10.1016\/j.jcv.2020.104539_bib0050","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","author":"To","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"10.1016\/j.jcv.2020.104539_bib0055","doi-asserted-by":"crossref","DOI":"10.3201\/eid2607.200841","article-title":"Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg. Infect. Dis."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665322030281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665322030281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:14:58Z","timestamp":1761362098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138665322030281X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":11,"alternative-id":["S138665322030281X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104539","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104539"}}